Referenzen
Hoepner R et al. Multiple Sclerosis J 2016
Warnke C et al. Der Nervenarzt 2016; 87: 1300–4
Literatur
Bargiela D, Bianchi MT, Westover MB et al. Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis. Neurology 2017; 88: 677–84
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gold, R. Modellierung von Risiken und Nutzen. InFo Neurologie 19, 16–17 (2017). https://doi.org/10.1007/s15005-017-2134-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15005-017-2134-0